Chiron Real Estate (XRN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Portfolio occupancy at quarter-end was 96.1% with a weighted average lease term of 5.6 years and a rent coverage ratio of 4.6x.
Net income attributable to common shareholders was $1.8 million ($0.03/share), down from $3.1 million ($0.05/share) year-over-year.
Rental revenue for Q3 2024 was $34.2 million, down 3.7% year-over-year, mainly due to lower occupancy and tenants on cash basis accounting.
Major acquisition activity included closing on a 15-property portfolio for $80.3 million and entering contracts for a $69.6 million five-property portfolio at a 9.0% cap rate, expected to close in 2025.
Steward Health Care bankruptcy led to lease rejection; a new 15-year lease with CHRISTUS Health at Beaumont Facility will commence rent in March or April 2025.
Financial highlights
Total revenues for Q3 2024 were $34.3 million, down from $35.5 million in Q3 2023.
FFO for Q3 2024 was $13.7 million ($0.19/share), down from $15.3 million ($0.22/share) year-over-year; AFFO was $15.3 million ($0.22/share), compared to $16.5 million ($0.23/share) in Q3 2023.
Nine-month 2024 net loss attributable to common stockholders was $0.6 million, compared to net income of $15.6 million in 2023, reflecting a $1.6 million loss on property sales.
Dividends per share of common stock were $0.21 for Q3 2024 and $0.63 for the nine months ended September 30, 2024.
Weighted average shares and units outstanding for Q3 2024 was 71.2 million.
Outlook and guidance
Management expects to complete the $69.6 million five-property acquisition in two tranches during the first half of 2025, subject to customary conditions.
Projected 2024 capital expenditures are $12–$14 million.
Quarterly G&A expenses are expected to remain in the $4.4–$4.6 million range.
Retention rate for 2024 lease expirations is trending toward 85%.
Management anticipates continued pressure from elevated interest rates and healthcare wage inflation, but expects demographic trends and outpatient care shifts to support long-term demand.
Latest events from Chiron Real Estate
- Strategic shift to senior housing, strong NOI growth, and 2026 Core FFO guidance of $4.30–$4.45.XRN
Q4 202526 Feb 2026 - Q2 net loss from property sale, but occupancy and AFFO remain strong; acquisitions ongoing.XRN
Q2 20242 Feb 2026 - Q4 2024 saw strong net income, stable AFFO, and growth via acquisitions and a new joint venture.XRN
Q4 20242 Dec 2025 - Annual meeting to vote on directors, pay, auditor; 2024 saw acquisitions and ESG progress.XRN
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.XRN
Proxy Filing2 Dec 2025 - Q1 2025 net income up, AFFO guidance reaffirmed, portfolio expands, tenant risk persists.XRN
Q1 202526 Nov 2025 - AFFO and FFO rose, occupancy held at 94.5%, and dividend was cut to support future growth.XRN
Q2 202523 Nov 2025 - Q3 2025 net loss from impairment, but FFO/AFFO and rental revenue grew year-over-year.XRN
Q3 202513 Nov 2025